Clinical Trial Update: Gene Therapy for DME [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 gene therapy trial for diabetic macular edema sponsored by Frontera Therapeutics is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Snippet

Sponsor: Frontera Therapeutics | Conditions: Diabetic Macular Edema | Phase 1, Phase 2 | Status: RECRUITING